ANIP Stockholders Approve Amended 2022 Stock Incentive Plan, Elect 7 Directors, Ratify Ernst & Young LLP as Auditor
ANI Pharmaceuticals, Inc. · PHARMACEUTICAL PREPARATIONS · Now $76.71
-1.2% in 3d after detection
Post-detection moves
1h
—
1d
-0.1%
3d
-1.2%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS